Source: ClinicalTrials.gov
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
View on ClinicalTrials.govCitation record
- Study start
- 2017-11-03
- NCT number
- NCT03878706
- Overall status
- Recruiting
- Study type
- Observational
- Lead sponsor
- University of Athens
- Enrollment
- 240 participants
- Conditions
- Diabetes Mellitus, Type 2
- Last updated at source
- 13 Mar 2026
- Original source
- https://clinicaltrials.gov/study/NCT03878706
This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.